Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up

Donor clonal hematopoiesis may be transferred to the recipient through allogeneic hematopoietic stem cell transplantation (HSCT), but the potential for adverse long-term impact on transplant outcomes remains unknown. A total of 744 samples from 372 recipients who received HSCT and the corresponding...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyoung Ha, Kim, TaeHyung, Novitzky-Basso, Igor, Lee, Hyewon, Yoo, Youngseok, Ahn, Jae-Sook, Pasic, Ivan, Law, Arjun, Lam, Wilson, Michelis, Fotios V., Gerbitz, Armin, Viswabandya, Auro, Lipton, Jeffrey, Kumar, Rajat, Mattsson, Jonas, Zhang, Zhaolei, Kaushansky, Nathali, Brilon, Yardena, Chapal-Ilani, Noa, Biezuner, Tamir, Shlush, Liran I., Kim, Dennis Dong Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Article - Bone Marrow Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316278/
https://www.ncbi.nlm.nih.gov/pubmed/36727396
http://dx.doi.org/10.3324/haematol.2022.281806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316278/
https://www.ncbi.nlm.nih.gov/pubmed/36727396
http://dx.doi.org/10.3324/haematol.2022.281806

Ejemplares similares